PT3126528T - Métodos para determinar a responsividade a inibidores de mek/erk - Google Patents
Métodos para determinar a responsividade a inibidores de mek/erkInfo
- Publication number
- PT3126528T PT3126528T PT157738402T PT15773840T PT3126528T PT 3126528 T PT3126528 T PT 3126528T PT 157738402 T PT157738402 T PT 157738402T PT 15773840 T PT15773840 T PT 15773840T PT 3126528 T PT3126528 T PT 3126528T
- Authority
- PT
- Portugal
- Prior art keywords
- mek
- methods
- erk inhibitors
- determining responsiveness
- responsiveness
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410135569 | 2014-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3126528T true PT3126528T (pt) | 2021-09-09 |
Family
ID=54239415
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT157738402T PT3126528T (pt) | 2014-04-04 | 2015-04-03 | Métodos para determinar a responsividade a inibidores de mek/erk |
| PT15772589T PT3126521T (pt) | 2014-04-04 | 2015-04-03 | Gene de fusão hnf4g-rspo2 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT15772589T PT3126521T (pt) | 2014-04-04 | 2015-04-03 | Gene de fusão hnf4g-rspo2 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10501805B2 (pt) |
| EP (3) | EP3126528B1 (pt) |
| CN (3) | CN111808957A (pt) |
| DK (2) | DK3126528T3 (pt) |
| ES (2) | ES2727374T3 (pt) |
| PT (2) | PT3126528T (pt) |
| WO (2) | WO2015149721A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200255901A1 (en) * | 2016-08-04 | 2020-08-13 | Shizuoka Prefecture | Method for determining presence or absence of risk of developing cancer |
| US11612643B2 (en) | 2016-09-30 | 2023-03-28 | Genoimmune Therapeutics Co, , Ltd. | Col14A1-derived tumor antigen polypeptide and use thereof |
| JP2022517563A (ja) * | 2019-01-02 | 2022-03-09 | チョーチアン クラウンマブ バイオテック カンパニー リミテッド | タンパク質キナーゼバイオマーカーと組み合わせた、多標的キナーゼ阻害剤を使用したがんの処置 |
| CN111434353A (zh) * | 2019-02-02 | 2020-07-21 | 中国科学院上海营养与健康研究所 | Ras抑制剂筛选及疗效标志物 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4503035B1 (en) | 1978-11-24 | 1996-03-19 | Hoffmann La Roche | Protein purification process and product |
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US5231176A (en) | 1984-08-27 | 1993-07-27 | Genentech, Inc. | Distinct family DNA encoding of human leukocyte interferons |
| DE69032864T3 (de) | 1989-03-29 | 2013-01-31 | The Johns Hopkins University | Nachweis des Ausfalls des Wildtyps des p53-Gens |
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US6177401B1 (en) | 1992-11-13 | 2001-01-23 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften | Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| US5880141A (en) | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
| ES2206602T3 (es) | 1995-10-23 | 2004-05-16 | The Children's Medical Center Corporation | Compuestos y metodos terapeuticos inhibidores de angiogenesis. |
| EP0858467B1 (en) | 1995-11-23 | 2004-02-11 | Cancer Research Campaign Technology Limited | Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| US6291455B1 (en) | 1996-03-05 | 2001-09-18 | Zeneca Limited | 4-anilinoquinazoline derivatives |
| AU3693697A (en) | 1996-07-13 | 1998-02-09 | Glaxo Group Limited | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
| JP2002511852A (ja) | 1997-05-07 | 2002-04-16 | スージェン・インコーポレーテッド | 蛋白質キナーゼ活性の調節剤としての２−インドリノン誘導体 |
| AU734009B2 (en) | 1997-05-30 | 2001-05-31 | Merck & Co., Inc. | Novel angiogenesis inhibitors |
| JP4959049B2 (ja) | 1997-08-22 | 2012-06-20 | アストラゼネカ・ユーケイ・リミテッド | 血管新生阻害剤としてのオキシインドリルキナゾリン誘導体 |
| EP1017682A4 (en) | 1997-09-26 | 2000-11-08 | Merck & Co Inc | NEW ANGIOGENESIS INHIBITORS |
| EA005889B1 (ru) | 1997-11-11 | 2005-06-30 | Пфайзер Продактс Инк. | Производные тиенопиримидина и тиенопиридина, полезные в качестве противораковых агентов |
| TR200003514T2 (tr) | 1998-05-29 | 2002-05-21 | Sugen Inc. | Pirol ikame edilmiş 2-indolinon protein kinaz inhibitörleri |
| UA60365C2 (uk) | 1998-06-04 | 2003-10-15 | Пфайзер Продактс Інк. | Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця |
| US7250496B2 (en) | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
| RU2448109C2 (ru) | 2006-08-08 | 2012-04-20 | Чугаи Сейяку Кабусики Кайся | Производное пиримидина в качестве ингибитора pi3k и его применение |
| US20100004253A1 (en) | 2006-09-19 | 2010-01-07 | Novartis Ag | Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors |
| TW200938201A (en) | 2008-02-07 | 2009-09-16 | Chugai Pharmaceutical Co Ltd | Pyrrolopyrimidine derivative as PI3K inhibitor and use thereof |
| CN101524529B (zh) | 2008-03-04 | 2011-09-28 | 中国人民解放军第二军医大学 | HNF4α诱导分化治疗人体恶性实体瘤 |
| WO2010096660A2 (en) | 2009-02-19 | 2010-08-26 | Cornell University | Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript |
| JP2012525149A (ja) | 2009-04-27 | 2012-10-22 | オンコメッド ファーマシューティカルズ インコーポレイテッド | ヘテロ多量体分子を作製するための方法 |
| US8945556B2 (en) | 2010-11-19 | 2015-02-03 | The Regents Of The University Of Michigan | RAF gene fusions |
| KR20130116291A (ko) | 2010-11-19 | 2013-10-23 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | Braf 억제제를 이용한 치료 방법 |
| US20140024539A1 (en) * | 2011-02-02 | 2014-01-23 | Translational Genomics Research Institute | Biomarkers and methods of use thereof |
| CN103571848B (zh) | 2012-08-10 | 2016-06-29 | 安徽医科大学第一附属医院 | 点状掌跖角化病的致病基因及其用途 |
-
2015
- 2015-04-03 WO PCT/CN2015/075884 patent/WO2015149721A1/en active Application Filing
- 2015-04-03 US US15/301,379 patent/US10501805B2/en active Active
- 2015-04-03 DK DK15773840.2T patent/DK3126528T3/da active
- 2015-04-03 ES ES15772589T patent/ES2727374T3/es active Active
- 2015-04-03 CN CN202010591503.6A patent/CN111808957A/zh active Pending
- 2015-04-03 PT PT157738402T patent/PT3126528T/pt unknown
- 2015-04-03 EP EP15773840.2A patent/EP3126528B1/en active Active
- 2015-04-03 PT PT15772589T patent/PT3126521T/pt unknown
- 2015-04-03 CN CN201580028218.0A patent/CN106536753B/zh active Active
- 2015-04-03 US US15/301,381 patent/US10683550B2/en active Active
- 2015-04-03 DK DK15772589.6T patent/DK3126521T3/da active
- 2015-04-03 EP EP15772589.6A patent/EP3126521B1/en active Active
- 2015-04-03 CN CN201580029656.9A patent/CN106460060B/zh active Active
- 2015-04-03 WO PCT/CN2015/075882 patent/WO2015149720A1/en active Application Filing
- 2015-04-03 EP EP21170371.5A patent/EP4012049A3/en not_active Withdrawn
- 2015-04-03 ES ES15773840T patent/ES2896404T3/es active Active
-
2019
- 2019-10-30 US US16/667,932 patent/US20200123622A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20200123622A1 (en) | 2020-04-23 |
| EP3126528A1 (en) | 2017-02-08 |
| DK3126521T3 (da) | 2019-06-17 |
| CN106536753A (zh) | 2017-03-22 |
| WO2015149721A1 (en) | 2015-10-08 |
| CN106460060A (zh) | 2017-02-22 |
| US20170114414A1 (en) | 2017-04-27 |
| CN106460060B (zh) | 2020-02-11 |
| US10501805B2 (en) | 2019-12-10 |
| CN111808957A (zh) | 2020-10-23 |
| ES2896404T3 (es) | 2022-02-24 |
| EP3126521B1 (en) | 2019-03-20 |
| EP3126528A4 (en) | 2018-02-21 |
| EP3126521A4 (en) | 2017-11-08 |
| EP4012049A3 (en) | 2022-08-24 |
| PT3126521T (pt) | 2019-06-27 |
| CN106536753B (zh) | 2020-07-21 |
| EP3126528B1 (en) | 2021-08-18 |
| WO2015149720A1 (en) | 2015-10-08 |
| EP3126521A1 (en) | 2017-02-08 |
| US10683550B2 (en) | 2020-06-16 |
| EP4012049A2 (en) | 2022-06-15 |
| ES2727374T3 (es) | 2019-10-15 |
| US20180282814A1 (en) | 2018-10-04 |
| DK3126528T3 (da) | 2021-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287113A (en) | smyd inhibitors | |
| IL251584B (en) | Dihydropyrrolopyridines ror–gamma inhibitors | |
| CL2016002736A1 (es) | Inhibidores de demetilasa-1 específico de lisina | |
| IL246902B (en) | Dihydropyrrolopyridine ror–gamma inhibitors | |
| IL246785A0 (en) | Benzimidazole-2-amines as midh1 inhibitors | |
| GB201421083D0 (en) | Enzyme inhibitors | |
| GB201421088D0 (en) | New enzyme inhibitors | |
| HK1226398A1 (zh) | 作為midh1抑制劑的苯並咪唑-2-胺 | |
| IL248895A0 (en) | Phosphatidylinositol 3-kinase inhibitors | |
| EP3140427A4 (en) | Biomarkers for response to pi3k inhibitors | |
| GB201421085D0 (en) | New enzyme inhibitors | |
| GB2540917B (en) | Solid acid scale inhibitors | |
| DK3191487T3 (da) | Spirocykliske cathepsin-c-inhibitorer | |
| ZA201608555B (en) | Biomarkers for response to ezh2 inhibitors | |
| PT3126528T (pt) | Métodos para determinar a responsividade a inibidores de mek/erk | |
| EP3237887C0 (en) | METHOD FOR DETERMINING SURFACE-RELATED RESISTANCE | |
| GB201400299D0 (en) | Corrosion inhibitors | |
| GB201418154D0 (en) | Inhibitors | |
| GB201420375D0 (en) | Method of detecting amp | |
| GB201400300D0 (en) | Corrosion inhibitors | |
| GB201320835D0 (en) | HIF inhibitors |